Dexamethasone protects the hearing of Meniere's disease patients after triple semicircular canal plugging
Dexamethasone protects the hearing of Meniere's disease patients after triple semicircular canal plugging
复制标题
地塞米松对三联半规管封堵后梅尼埃病患者听力的保护作用
DOI:
10.1080/00016489.2020.1775292
复制
发表时间:
2020-06-18
影响因子:
1.4
通讯作者:
Wang, Haibo
中科院分区:
文献类型:
--
作者:
Lyu, Yafeng;Zhang, Daogong;Wang, Haibo
Background:TSCP has shown its efficacy in vertigo control for intractable Meniere's disease. However, hearing impairment remains a problem and hampered the application of the surgery. Aims/objectives:To investigate the effect of dexamethasone on the hearing of Meniere's disease patients after TSCP to determine whether inflammation is involved in this process Material and methods:Meniere's disease patients who received TSCP surgeries were treated with or without dexamethasone postoperatively. All patients' hearing function were evaluated during a follow up of 2 years after surgery and compared between the two groups. Results:Hearing worsening and word recognition score loss were milder in the dexamethasone group than in the non-dexamethasone group. The rates of profound hearing worsening and word recognition score loss remained significantly lower in the dexamethasone group than in the non-dexamethasone group even 2 years after surgery. Conclusions:Dexamethasone protects the hearing of Meniere's patients after TSCP. Inflammation may be involved in the mechanism by which TSCP causes hearing impairment in these patients. Significance:This finding suggests that steroids should be used routinely after TSCP for hearing preservation, and operative precedures need to be modified to minimize inflammation in the inner ear.